Oct 21, 2024
Therapeutic options for frontline management of epidermal growth
factor receptor (EGFR)-mutated non-small cell lung cancer
(NSCLC) are rapidly evolving. Are you up to date on the
evidence?
Credit available for this activity expires: 09/27/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu